Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Gembus

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Medicinal Chemistry|January 12, 2018
Novel donepezil-like N-benzylpyridinium salt derivatives as AChE inhibitors and their corresponding dihydropyridine "bio-oxidizable" prodrugs: Synthesis, biological evaluation and structure-activity relationshipRabah Azzouz, Ludovic Peauger, Vincent Gembus, et al.
The Journal of Organic Chemistry|July 14, 2018
Access to Highly Enantioenriched Donepezil-like 1,4-Dihydropyridines as Promising Anti-Alzheimer Prodrug Candidates via Enantioselective Tsuji Allylation and Organocatalytic Aza-Ene-Type Domino ReactionsMihaela-Liliana Ţînţaş, Rabah Azzouz, Ludovic Peauger, et al.
Journal of Medicinal Chemistry|June 15, 2017
Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a "Bio-Oxidizable" Prodrug Strategy: Design, Synthesis, and in Vitro Biological EvaluationLudovic Peauger, Rabah Azzouz, Vincent Gembus, et al.
RSC Medicinal Chemistry|March 22, 2024
Design, synthesis and preliminary biological evaluation of rivastigmine-INDY hybrids as multitarget ligands against Alzheimer's disease by targeting butyrylcholinesterase and DYRK1A/CLK1 kinasesMihaela-Liliana Ţînţaş, Ludovic Peauger, Anaïs Barré, et al.
European Journal of Medicinal Chemistry|June 11, 2018
Rational design of carbamate-based dual binding site and central AChE inhibitors by a "biooxidisable" prodrug approach: Synthesis, in vitro evaluation and docking studiesMihaela-Liliana Ţînţaş, Vincent Gembus, Florent Alix, et al.
Molecules (Basel, Switzerland)|January 8, 2023
Straightforward Access to a New Class of Dual DYRK1A/CLK1 Inhibitors Possessing a Simple Dihydroquinoline CoreMihaela-Liliana Ţînţaş, Ludovic Peauger, Florent Alix, et al.
ACS Chemical Neuroscience|February 20, 2015
Dihydroquinoline Carbamate Derivatives as "Bio-oxidizable" Prodrugs for Brain Delivery of Acetylcholinesterase Inhibitors: [¹¹C] Radiosynthesis and Biological EvaluationPierre Bohn, Fabienne Gourand, Cyril Papamicaël, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Medicinal Chemistry|January 12, 2018
Novel donepezil-like N-benzylpyridinium salt derivatives as AChE inhibitors and their corresponding dihydropyridine "bio-oxidizable" prodrugs: Synthesis, biological evaluation and structure-activity relationshipRabah Azzouz, Ludovic Peauger, Vincent Gembus, et al.
The Journal of Organic Chemistry|July 14, 2018
Access to Highly Enantioenriched Donepezil-like 1,4-Dihydropyridines as Promising Anti-Alzheimer Prodrug Candidates via Enantioselective Tsuji Allylation and Organocatalytic Aza-Ene-Type Domino ReactionsMihaela-Liliana Ţînţaş, Rabah Azzouz, Ludovic Peauger, et al.
Journal of Medicinal Chemistry|June 15, 2017
Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a "Bio-Oxidizable" Prodrug Strategy: Design, Synthesis, and in Vitro Biological EvaluationLudovic Peauger, Rabah Azzouz, Vincent Gembus, et al.
RSC Medicinal Chemistry|March 22, 2024
Design, synthesis and preliminary biological evaluation of rivastigmine-INDY hybrids as multitarget ligands against Alzheimer's disease by targeting butyrylcholinesterase and DYRK1A/CLK1 kinasesMihaela-Liliana Ţînţaş, Ludovic Peauger, Anaïs Barré, et al.
European Journal of Medicinal Chemistry|June 11, 2018
Rational design of carbamate-based dual binding site and central AChE inhibitors by a "biooxidisable" prodrug approach: Synthesis, in vitro evaluation and docking studiesMihaela-Liliana Ţînţaş, Vincent Gembus, Florent Alix, et al.
Molecules (Basel, Switzerland)|January 8, 2023
Straightforward Access to a New Class of Dual DYRK1A/CLK1 Inhibitors Possessing a Simple Dihydroquinoline CoreMihaela-Liliana Ţînţaş, Ludovic Peauger, Florent Alix, et al.
ACS Chemical Neuroscience|February 20, 2015
Dihydroquinoline Carbamate Derivatives as "Bio-oxidizable" Prodrugs for Brain Delivery of Acetylcholinesterase Inhibitors: [¹¹C] Radiosynthesis and Biological EvaluationPierre Bohn, Fabienne Gourand, Cyril Papamicaël, et al.
Pageof 2